Discontinued — last reported Q4 '25
Contract-Manufactured Products — CapEx
West Pharmaceutical Services Contract-Manufactured Products — CapEx increased by 34.6% to $18.30M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 24.4%, from $24.20M to $18.30M. Over 4 years (FY 2021 to FY 2025), Contract-Manufactured Products — CapEx shows an upward trend with a 29.8% CAGR.
Analysis
How to read this metric
Higher spending suggests growth initiatives or facility upgrades, while lower spending may indicate a focus on cash preservation or a mature asset base.
Detailed definition
This metric tracks the cash outflows used by the Contract-Manufactured Products segment to acquire, upgrade, and maintai...
Peer comparison
Commonly tracked by industrial and contract manufacturing firms to assess long-term growth investment versus maintenance requirements.
wst_segment_contract_manufactured_products_capital_expendituresHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.65M | $6.65M | $6.65M | $8.50M | $8.50M | $8.50M | $8.50M | $22.55M | $22.55M | $22.55M | $22.55M | $27.60M | $39.20M | $30.00M | $24.20M | $18.10M | $25.50M | $13.60M | $18.30M |
| QoQ Change | — | +0.0% | +0.0% | +27.8% | +0.0% | +0.0% | +0.0% | +165.3% | +0.0% | +0.0% | +0.0% | +22.4% | +42.0% | -23.5% | -19.3% | -25.2% | +40.9% | -46.7% | +34.6% |
| YoY Change | — | — | — | — | +27.8% | +27.8% | +27.8% | +165.3% | +165.3% | +165.3% | +165.3% | +22.4% | +73.8% | +33.0% | +7.3% | -34.4% | -34.9% | -54.7% | -24.4% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's contract-manufactured products — capex?
- West Pharmaceutical Services (WST) reported contract-manufactured products — capex of $18.30M in Q4 2025.
- How has West Pharmaceutical Services's contract-manufactured products — capex changed year-over-year?
- West Pharmaceutical Services's contract-manufactured products — capex decreased by 24.4% year-over-year, from $24.20M to $18.30M.
- What is the long-term trend for West Pharmaceutical Services's contract-manufactured products — capex?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's contract-manufactured products — capex has grown at a 29.8% compound annual growth rate (CAGR), from $26.60M to $75.50M.
- What does contract-manufactured products — capex mean?
- The amount of money spent on physical assets and infrastructure to support the contract manufacturing segment.